Elizabethkingia miricola Recovered from a Peritoneal Fluid Sample – A Clinical Case Report with Diagnostic Challenges
DOI:
https://doi.org/10.3889/oamjms.2022.7716Keywords:
Elizabethkingia miricola, Immunosuppression, BacterascitesAbstract
Background: Elizabethkingia spp. are Gram-negative, non-spore-forming bacteria that used to be rarely encountered but now they are of growing clinical significance. Furthermore, the diagnostic challenges to identification impede the complete elucidation of their epidemiology and association with human diseases. Case report: A 64-year-old man with liver cirrhosis due to alcohol abuse presented with fatigue, abdominal swelling, and bilateral scrotal edema. A peritoneal fluid sample was cultured and subject to a number of identification methods – API 20 NE (bioMerieux), automated Vitek-2 Compact (bioMerieux), MALDI-TOF MS (Vitek-MS, bioMerieux), and 16S rRNA gene sequencing. A final diagnosis of bacterascites was made on the basis of clinical, laboratory, and microbiological findings. Conclusion: To the best of our knowledge this is the first report of Elizabethkingia miricola being cultured from a peritoneal fluid sample in an immune-compromised host thus pointing to the emerging pathogenic role of the bacterium in patients with liver cirrhosis and ascites.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Li Y, Kawamura Y, Fujiwara N, Naka T, Liu H, Huang X, et al. Chryseobacterium miricola sp. nov., a novel species isolated from condensation water of space station mir. Syst Appl Microbiol. 2003;26(4):523-528. https://doi.org/10.1078/072320203770865828 PMid:14666980
Green O, Murray P, Gea-Banacloche JC. Sepsis caused by Elizabethkingia miricola successfully treated with tigecycline and levofloxacin. Diagn Microbiol Infect Dis. 2008;62(4):430-2. https://doi.org/10.1016/j.diagmicrobio.2008.07.015 PMid:18842380
Gonzalez C, Coolen-Allou N, Allyn J, Estève JB, Belmonte O, Allou N. Sepsis grave lié à un abcès pulmonaire avec bactériémie à Elizabethkingia miricola. Médecine Mal Infect. 2016;46(1):49-51. https://doi.org/10.1016/j.medmal.2015.10.011
Gupta P, Zaman K, Mohan B, Taneja N. Elizabethkingia miricola: A rare non-fermenter causing urinary tract infection. World J Clin cases. 2017;5(5):187-90. https://doi.org/10.12998/wjcc.v5.i5.187 PMid:28560237
Frost F, Nazareth D. Case report: First report of Elizabethkingia miricola infection in a patient with cystic fibrosis. F1000Research. 2018;7:440. https://doi.org/10.12688/f1000research.14441.2 PMid:30079241
Lin JN, Lai CH, Yang CH, Huang YH, Lin HH. Complete genome sequence of Elizabethkingia miricola strain EM798-26 isolated from the blood of a cancer patient. Genome Announc. 2018;6(1):e01408-17. https://doi.org/10.1128/genomeA.01408-17 PMid:29301886
Zdziarski P, Paściak M, Rogala K, Korzeniowska-Kowal A, Gamian A. Elizabethkingia miricola as an opportunistic oral pathogen associated with superinfectious complications in humoral immunodeficiency: A case report. BMC Infect Dis. 2017;17(1):763. https://doi.org/10.1186/s12879-017-2886-7
Kenna DT, Fuller A, Martin K, Perry C, Pike R, Burns PJ, et al. rpoB gene sequencing highlights the prevalence of an E. miricola cluster over other Elizabethkingia species among UK cystic fibrosis patients. Diagn Microbiol Infect Dis. 2018;90(2):109-14. https://doi.org/10.1016/j.diagmicrobio.2017.10.014 PMid:29174734
Choi MH, Kim M, Jeong SJ, Choi JY, Lee IY, Yong TS, et al. Risk factors for Elizabethkingia acquisition and clinical characteristics of patients, South Korea. Emerg Infect Dis. 2019;25(1):42-51. https://doi.org/10.3201/EID2501.171985 PMid:30561316
Yoon SH, Ha SM, Kwon S, Lim J, Kim Y, Seo H, et al. Introducing EzBioCloud: A taxonomically united database of 16S rRNA gene sequences and whole-genome assemblies. Int J Syst Evol Microbiol. 2017;67(5):1613-7. https://doi.org/10.1099/ijsem.0.001755 PMid:28005526
Lin JN, Lai CH, Yang CH, Huang YH. Elizabethkingia infections in humans: From genomics to clinics. Microorganisms. 2019;7(9):295. https://doi.org/10.3390/MICROORGANISMS7090295 PMid:31466280
Eriksen HB, Gumpert H, Faurholt CH, Westh H. Determination of Elizabethkingia diversity by MALDI-TOF mass spectrometry and whole-genome sequencing. Emerg Infect Dis. 2017;23(2):320-323. https://doi.org/10.3201/eid2302.161321 PMid:28098550
Cheng YH, Perng CL, Jian MJ, Lee SY, Sun JR, Shang HS. Multicentre study evaluating matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of clinically isolated Elizabethkingia species and analysis of antimicrobial susceptibility. Clin Microbiol Infect. 2019;25(3):340-5. https://doi.org/10.1016/j.cmi.2018.04.015 PMid:29689427
Runyon BA. Polymicrobial bacterascites. A unique entity in the spectrum of infected ascitic fluid. Arch Intern Med. 1986;146(11):2173-5. https://doi.org/10.1001/archinte.146.11.2173 PMid:3778046
Jean SS, Lee WS, Chen FL, Ou TY, Hsueh PR. Elizabethkingia meningoseptica: An important emerging pathogen causing healthcare-associated infections. J Hosp Infect. 2014;86(4):244-9. https://doi.org/10.1016/j.jhin.2014.01.009 PMid:24680187
Ginès P, Angeli P, Lenz K. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol. 2010;53(3):397-417. https://doi.org/10.1016/j.jhep.2010.05.004 PMid:20633946
Rimola A, García-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: A consensus document. J Hepatol. 2000;32(1):142-53. https://doi.org/10.1016/S0168-8278(00)80201-9 PMid:10673079
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2022 Yordan Kalchev, Atanaska Petrova, Gergana Lengerova, Ivan Ivanov, Mariyana Murdjeva (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0)
